To update and integrate the recommendations for ankylosing spondylitis and the recommendations
for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA…

This first update of the ASAS/EULAR recommendations on the management of ankylosing
spondylitis (AS) is based on the original paper, a systematic review of existing …

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-EULAR
recommendations for the management of axial spondyloarthritis (axSpA). Methods …

Regular physical activity (PA) is increasingly promoted for people with rheumatic and
musculoskeletal diseases as well as the general population. We evaluated if the public health …

Background Patients who have had inadequate response to tumour necrosis factor inhibitors
have fewer treatment options and are generally more treatment refractory to subsequent …

Objective Patients with axial spondylarthritis (SpA) who have structural changes in the
sacroiliac joints and/or the spine have been classified as having ankylosing spondylitis (AS), …

Introduction The objective was to develop a questionnaire that can be used to calculate a
score reflecting the impact of psoriatic arthritis (PsA) from the patients’ perspective: the PsA …

Background Increased risk of some comorbidities has been reported in spondyloarthritis (SpA).
Recommendations for detection/management of some of these comorbidities have been …

Objectives To characterise peripheral musculoskeletal involvement in patients with
spondyloarthritis (SpA) including psoriatic arthritis (PsA), across the world. Methods Cross-sectional …

Objectives To evaluate construct validity, interpretability, reliability and responsiveness as
well as determination of cut-off points for good and poor health within the original English …